SlideShare a Scribd company logo
1 of 31
Karunav
Final Year MBBS Student
Punjab Institute of Medical Sciences, Jalandhar
Hypertensive Disorders of
Pregnancy
(karunav4301@gmail.com)
Hypertensive disorders of Pregnancy
(Topics to be covered)
• Epidemiology
• Definitions
• Diagnostic criteria
• Risk Factors
• Etiology
• Pathogenesis
2
Epidemiology of Hypertensive Disorders in
Pregnancy
‣ They constitute one of the leading causes of maternal and perinatal
mortality worldwide.
‣ Highest incidence is present in primigravidae patients and patients in the
age group of 18-22 years.
‣ It has been estimated that preeclampsia complicates 2–8% of pregnancies
globally.
‣ Associated with maternal complications: APH, PPH, Hepatic Failure,
RF
‣ Associated with fetal complications: FGR, Preterm birth, perinatal
death.
‣ Hypertensive disorders of pregnancy contribute to 9% of maternal deaths
in Asia.
Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020
3
Definition
s
4
Gestational Hypertension
It is the case of hypertension which is diagnosed after 20 weeks of
gestation in a previously normotensive female but is not associated
with proteinuria and/ or end organ damage.
5
PreEclampsia
It is defined as the new onset hypertension (BP 140/90 mmHg) which is
diagnosed after 20 weeks of gestation in a previously normotensive
female and is associated with proteinuria and/or end organ damage.
6
Eclampsia
It is defined by new-onset tonic-clonic, focal, or multifocal seizures in
the absence of other causative conditions (such as epilepsy, cerebral
arterial ischemia) which presents as a convulsive complication of
hypertensive disorders of pregnancy.
7
Chronic Hypertension
It is defined as case of hypertension which is diagnosed before 20 weeks of
gestation and persists longer than 12 weeks after delivery.
 Causes:
1. Primary hypertension: Essential hypertension
2.Secondary hypertension: renal disease, coarctation of aorta, SLE
etc.
8
Superimposed PreEclampsia-Eclampsia
(in Chronic Hypertension)
It is defined as the occurrence of proteinuria and/or signs of end organ
dysfunction in a patient with chronic hypertension.
9
Diagnosis of Hypertension in pregnancy
• Absolute criteria: A systolic blood pressure of 140 mm Hg and diastolic blood
pressure of 90mm Hg.
• Relative criteria: A rise in 30 mm Hg in systolic and 15mm Hg in diastolic blood
pressure in previously known BP.
• Mean arterial pressure criteria: A rise of over 20mm Hg in the MAP or MAP
>105mm Hg (25th percentile). Though the SBP/DBP is <140/90 in this case. (delta
hypertension).
Source: DC Dutta’s textbook of obstetrics-10/e-pg210
10
Arm Circumference Cuff Size
Upto 33cm Standard size
(13x23cm)
33-41cm Large size
(33x15cm)
>41cm Thigh cuff
(18x36)
Assessment of Blood Pressure
• Instrument: Mercury BP apparatus are preferable than
automated blood pressure monitors.
• appropriate size cuff:
Source: Action on preeclampsia community (APEC); www.apec.org.uk
11
Patient position: woman should be seated or lying at 45° angle, with
arm at level of the heart.
White Coat effect: blood pressure should be measured after rest of
5-10 mins.
Diagnostic Criteria for
PreEclampsia
12
Blood Pressure
1. BP >=140 / 90 mm Hg on two occasions at least 4 hours apart.
2. BP >=160 /110 mm Hg on two occasions at least 15-30 mins
apart.
Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020
1
POG: >20 weeks
patient have a previously normal BP
13
Proteinuria
1. 24hr urine protein: >/=300 mg/dL
2. Protein/creatinine ratio of >/= 0.3 mg/dL
3. Dipstick reading of 2+
2
Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020
14
Other Criteria
(in absence of proteinuria)
1. Thrombocytopenia: Platelet count < 1,00,000/mm3
2. Renal insufficiency: Serum creatinine concentrations >1.1 mg/dL or a
doubling of the serum creatinine concentration in the absence of
other renal disease.
3. Impaired liver function: Elevated blood concentrations of liver
transaminases to twice normal concentration.
4. Pulmonary edema
5. New-onset headache unresponsive to medication and not accounted
for any alternative diagnosis.
6. visual symptoms
3
Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020
15
Risk Factors for PreEclampsia
1. Nulliparity
2. Multifetal gestations
3. Preeclampsia in a previous
pregnancy
4. Chronic hypertension
5. Pregestational diabetes
6. Gestational diabetes
7. Thrombophilia
8. SLE
9. Prepregnancy BMI >30
10. Antiphospholipid antibody
syndrome
11.Maternal age 35 years or older
12.Kidney disease
13.Assisted reproductive technology
14.Obstructive sleep apnea
Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020
16
Etiology of PreEclampsia
ABNORMAL
INVASION
Placental
Implantation with
abnormal invasion of
uterine vessels
17
Etiology of PreEclampsia
ABNORMAL
INVASION
MALADAPTATION
Maternal maladaptation
to the CVS changes in
normal pregnancy.
18
Etiology of PreEclampsia
ABNORMAL
INVASION
MALADAPTATION
IMMUNE
Immunological
maladaptive tolerance
b/w maternal, placental
and fetal tissues.
19
Etiology of PreEclampsia
ABNORMAL
INVASION
MALADAPTATION IMMUNE
GENETIC
Inheritance of
predisposed genes
20
Etiology of PreEclampsia
ABNORMAL
INVASION
MALADAPTATION IMMUNE GENETIC
Source: Williams Obstetrics 25/e pg6/68
21
22
NORMAL PREGNANCY:
There is endovascular trophoblast invasion
into the spiral arterioles.
Ist trimester: up to decidual segments
IInd trimester: up to myometrial segments
LOW RESISTANCE LOW
PRESSURE HIGH FLOW SYSTEM
23
PREECLAMPSIA:
There is failure of second invasion of
trophoblast which reduces the blood
supply to fetoplacental unit.
24
Pathogenesis (PreEclampsia)
ABNORMAL
PLACENTATION
Abnormal
Placentation
Endothelial
Dysfunction
Intense
Vasospasm
25
Endothelial dysfunction
• Due to abnormal invasion, there is state of chronic hypoxia of the placenta.
• This causes the ER to activate apoptotic pathways, increasing the
oxidative stress and causes release of angiotensin-II, Endoglin and uric
acid.
• There is release of inflammatory mediators like TNF alpha, IL-6 etc.
• This increased systemic inflammatory response causes endothelial
damage.
• There is overproduction of antiangiogenic proteins like fms-like tyrosine
kinase and endoglin which bind to placental growth factor & VEGF and
causes endothelial dysfunction.
26
Vasospasm
INCREASED
VASOCONSTRICTORS
Thromboxane A2
Endothelin-1
INCREASED ANTIANGIOGENIC
PROTEINS
sFlt1
Endoglin
DECREASED VASODILATORS
Prostacyclin (PGI2)
Nitric Oxide
DECREASED ANGIOGENIC
GROWTH FACTORS
PlGF
VEGF
27
Pathogenesis of proteinuria
28
Pathogenesis of proteinuria
• Spasm of afferent arteriole
• Anoxic change in endothelium
• Glomerular endotheliosis
• Increased capillary
permeability
• Increased leakage of protein
29
Pathogenesis (contd.)
Increased
Vascular
Permeability
Third space
loss Edema Decreased
blood volume
Hemoconc.
Platelet
aggregation
Thrombosis
Organ
Failure
30
Thank
You
31
֍karunav4301@gmail.com֍

More Related Content

Similar to hypertensive disorders of pregnancy.pptx

CME Hypertension in Pregnancy yoges edited.pptx
CME Hypertension in Pregnancy yoges edited.pptxCME Hypertension in Pregnancy yoges edited.pptx
CME Hypertension in Pregnancy yoges edited.pptx
yogeswary7
 
WV-Talk-PPH-and-PreE-Copy.pptx
WV-Talk-PPH-and-PreE-Copy.pptxWV-Talk-PPH-and-PreE-Copy.pptx
WV-Talk-PPH-and-PreE-Copy.pptx
SunduzSaid
 

Similar to hypertensive disorders of pregnancy.pptx (20)

Evidence based Management Preeclampsia / eclampsia
Evidence based Management Preeclampsia / eclampsiaEvidence based Management Preeclampsia / eclampsia
Evidence based Management Preeclampsia / eclampsia
 
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019
Tăng huyết áp thai kỳ và tiền sản giật ACOG 2019
 
CME Hypertension in Pregnancy yoges edited.pptx
CME Hypertension in Pregnancy yoges edited.pptxCME Hypertension in Pregnancy yoges edited.pptx
CME Hypertension in Pregnancy yoges edited.pptx
 
CURRENT BEST PRACTICES IN THE MANAGEMENT OF PREECLAMPSIA.pptx
CURRENT BEST PRACTICES IN THE MANAGEMENT OF PREECLAMPSIA.pptxCURRENT BEST PRACTICES IN THE MANAGEMENT OF PREECLAMPSIA.pptx
CURRENT BEST PRACTICES IN THE MANAGEMENT OF PREECLAMPSIA.pptx
 
HTN in Pregnancy
HTN in PregnancyHTN in Pregnancy
HTN in Pregnancy
 
Hypertensive Disorders of Pregnancy .pdf
Hypertensive Disorders of Pregnancy .pdfHypertensive Disorders of Pregnancy .pdf
Hypertensive Disorders of Pregnancy .pdf
 
WV-Talk-PPH-and-PreE-Copy.pptx
WV-Talk-PPH-and-PreE-Copy.pptxWV-Talk-PPH-and-PreE-Copy.pptx
WV-Talk-PPH-and-PreE-Copy.pptx
 
Tatalaksana Preeklampsia dan Eklampsia Kuliah Pakar.pptx
Tatalaksana Preeklampsia dan Eklampsia Kuliah Pakar.pptxTatalaksana Preeklampsia dan Eklampsia Kuliah Pakar.pptx
Tatalaksana Preeklampsia dan Eklampsia Kuliah Pakar.pptx
 
(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension
 
Hypertensive in pregnancy new.pptx
Hypertensive in pregnancy new.pptxHypertensive in pregnancy new.pptx
Hypertensive in pregnancy new.pptx
 
Recent advances in management of PET
Recent advances in management of PET Recent advances in management of PET
Recent advances in management of PET
 
(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)
 
Hypertensive disorder in pregnancy - DIAGNOSIS AND MANAGEMENT
Hypertensive disorder in pregnancy - DIAGNOSIS AND MANAGEMENTHypertensive disorder in pregnancy - DIAGNOSIS AND MANAGEMENT
Hypertensive disorder in pregnancy - DIAGNOSIS AND MANAGEMENT
 
Liver disorder at pregnancy
Liver disorder at pregnancyLiver disorder at pregnancy
Liver disorder at pregnancy
 
Pregnancy with pulmonary hypertension
Pregnancy with pulmonary hypertension Pregnancy with pulmonary hypertension
Pregnancy with pulmonary hypertension
 
Gestational hypertension and preeclampsia 2020 Update
Gestational hypertension and preeclampsia   2020 UpdateGestational hypertension and preeclampsia   2020 Update
Gestational hypertension and preeclampsia 2020 Update
 
Pregnancy with rheumatic diseases
Pregnancy with rheumatic diseasesPregnancy with rheumatic diseases
Pregnancy with rheumatic diseases
 
Preeclampsia dr kobra shojaei2016
Preeclampsia dr kobra shojaei2016Preeclampsia dr kobra shojaei2016
Preeclampsia dr kobra shojaei2016
 
preeclampsiahennawy-180207195844 3.pdf
preeclampsiahennawy-180207195844 3.pdfpreeclampsiahennawy-180207195844 3.pdf
preeclampsiahennawy-180207195844 3.pdf
 
Preeclampsia
PreeclampsiaPreeclampsia
Preeclampsia
 

Recently uploaded

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Recently uploaded (20)

Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Pharmacology of drugs acting on Renal System.pdf
Pharmacology of drugs acting on Renal System.pdfPharmacology of drugs acting on Renal System.pdf
Pharmacology of drugs acting on Renal System.pdf
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 

hypertensive disorders of pregnancy.pptx

  • 1. Karunav Final Year MBBS Student Punjab Institute of Medical Sciences, Jalandhar Hypertensive Disorders of Pregnancy (karunav4301@gmail.com)
  • 2. Hypertensive disorders of Pregnancy (Topics to be covered) • Epidemiology • Definitions • Diagnostic criteria • Risk Factors • Etiology • Pathogenesis 2
  • 3. Epidemiology of Hypertensive Disorders in Pregnancy ‣ They constitute one of the leading causes of maternal and perinatal mortality worldwide. ‣ Highest incidence is present in primigravidae patients and patients in the age group of 18-22 years. ‣ It has been estimated that preeclampsia complicates 2–8% of pregnancies globally. ‣ Associated with maternal complications: APH, PPH, Hepatic Failure, RF ‣ Associated with fetal complications: FGR, Preterm birth, perinatal death. ‣ Hypertensive disorders of pregnancy contribute to 9% of maternal deaths in Asia. Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020 3
  • 5. Gestational Hypertension It is the case of hypertension which is diagnosed after 20 weeks of gestation in a previously normotensive female but is not associated with proteinuria and/ or end organ damage. 5
  • 6. PreEclampsia It is defined as the new onset hypertension (BP 140/90 mmHg) which is diagnosed after 20 weeks of gestation in a previously normotensive female and is associated with proteinuria and/or end organ damage. 6
  • 7. Eclampsia It is defined by new-onset tonic-clonic, focal, or multifocal seizures in the absence of other causative conditions (such as epilepsy, cerebral arterial ischemia) which presents as a convulsive complication of hypertensive disorders of pregnancy. 7
  • 8. Chronic Hypertension It is defined as case of hypertension which is diagnosed before 20 weeks of gestation and persists longer than 12 weeks after delivery.  Causes: 1. Primary hypertension: Essential hypertension 2.Secondary hypertension: renal disease, coarctation of aorta, SLE etc. 8
  • 9. Superimposed PreEclampsia-Eclampsia (in Chronic Hypertension) It is defined as the occurrence of proteinuria and/or signs of end organ dysfunction in a patient with chronic hypertension. 9
  • 10. Diagnosis of Hypertension in pregnancy • Absolute criteria: A systolic blood pressure of 140 mm Hg and diastolic blood pressure of 90mm Hg. • Relative criteria: A rise in 30 mm Hg in systolic and 15mm Hg in diastolic blood pressure in previously known BP. • Mean arterial pressure criteria: A rise of over 20mm Hg in the MAP or MAP >105mm Hg (25th percentile). Though the SBP/DBP is <140/90 in this case. (delta hypertension). Source: DC Dutta’s textbook of obstetrics-10/e-pg210 10
  • 11. Arm Circumference Cuff Size Upto 33cm Standard size (13x23cm) 33-41cm Large size (33x15cm) >41cm Thigh cuff (18x36) Assessment of Blood Pressure • Instrument: Mercury BP apparatus are preferable than automated blood pressure monitors. • appropriate size cuff: Source: Action on preeclampsia community (APEC); www.apec.org.uk 11 Patient position: woman should be seated or lying at 45° angle, with arm at level of the heart. White Coat effect: blood pressure should be measured after rest of 5-10 mins.
  • 13. Blood Pressure 1. BP >=140 / 90 mm Hg on two occasions at least 4 hours apart. 2. BP >=160 /110 mm Hg on two occasions at least 15-30 mins apart. Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020 1 POG: >20 weeks patient have a previously normal BP 13
  • 14. Proteinuria 1. 24hr urine protein: >/=300 mg/dL 2. Protein/creatinine ratio of >/= 0.3 mg/dL 3. Dipstick reading of 2+ 2 Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020 14
  • 15. Other Criteria (in absence of proteinuria) 1. Thrombocytopenia: Platelet count < 1,00,000/mm3 2. Renal insufficiency: Serum creatinine concentrations >1.1 mg/dL or a doubling of the serum creatinine concentration in the absence of other renal disease. 3. Impaired liver function: Elevated blood concentrations of liver transaminases to twice normal concentration. 4. Pulmonary edema 5. New-onset headache unresponsive to medication and not accounted for any alternative diagnosis. 6. visual symptoms 3 Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020 15
  • 16. Risk Factors for PreEclampsia 1. Nulliparity 2. Multifetal gestations 3. Preeclampsia in a previous pregnancy 4. Chronic hypertension 5. Pregestational diabetes 6. Gestational diabetes 7. Thrombophilia 8. SLE 9. Prepregnancy BMI >30 10. Antiphospholipid antibody syndrome 11.Maternal age 35 years or older 12.Kidney disease 13.Assisted reproductive technology 14.Obstructive sleep apnea Source: ACOG Practice Bulletin Vol. 135 No.6, June 2020 16
  • 17. Etiology of PreEclampsia ABNORMAL INVASION Placental Implantation with abnormal invasion of uterine vessels 17
  • 18. Etiology of PreEclampsia ABNORMAL INVASION MALADAPTATION Maternal maladaptation to the CVS changes in normal pregnancy. 18
  • 19. Etiology of PreEclampsia ABNORMAL INVASION MALADAPTATION IMMUNE Immunological maladaptive tolerance b/w maternal, placental and fetal tissues. 19
  • 20. Etiology of PreEclampsia ABNORMAL INVASION MALADAPTATION IMMUNE GENETIC Inheritance of predisposed genes 20
  • 21. Etiology of PreEclampsia ABNORMAL INVASION MALADAPTATION IMMUNE GENETIC Source: Williams Obstetrics 25/e pg6/68 21
  • 22. 22
  • 23. NORMAL PREGNANCY: There is endovascular trophoblast invasion into the spiral arterioles. Ist trimester: up to decidual segments IInd trimester: up to myometrial segments LOW RESISTANCE LOW PRESSURE HIGH FLOW SYSTEM 23
  • 24. PREECLAMPSIA: There is failure of second invasion of trophoblast which reduces the blood supply to fetoplacental unit. 24
  • 26. Endothelial dysfunction • Due to abnormal invasion, there is state of chronic hypoxia of the placenta. • This causes the ER to activate apoptotic pathways, increasing the oxidative stress and causes release of angiotensin-II, Endoglin and uric acid. • There is release of inflammatory mediators like TNF alpha, IL-6 etc. • This increased systemic inflammatory response causes endothelial damage. • There is overproduction of antiangiogenic proteins like fms-like tyrosine kinase and endoglin which bind to placental growth factor & VEGF and causes endothelial dysfunction. 26
  • 27. Vasospasm INCREASED VASOCONSTRICTORS Thromboxane A2 Endothelin-1 INCREASED ANTIANGIOGENIC PROTEINS sFlt1 Endoglin DECREASED VASODILATORS Prostacyclin (PGI2) Nitric Oxide DECREASED ANGIOGENIC GROWTH FACTORS PlGF VEGF 27
  • 29. Pathogenesis of proteinuria • Spasm of afferent arteriole • Anoxic change in endothelium • Glomerular endotheliosis • Increased capillary permeability • Increased leakage of protein 29
  • 30. Pathogenesis (contd.) Increased Vascular Permeability Third space loss Edema Decreased blood volume Hemoconc. Platelet aggregation Thrombosis Organ Failure 30